Insights into the Role and Interdependence of Oxidative Stress and Inflammation in Liver Diseases

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Li, Sha ^a   Hong, Ming ^a   Tan, Hor Yue ^a   Wang, Ning ^a   Feng, Yibin ^a  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

OXIDATIVE STRESS; PATHOLOGY;

ANTI-INFLAMMATION; ANTI-OXIDATION; HEPATIC DISEASE; HERBAL MEDICINES; IMMUNE SUPPRESSION; LIVER CANCERS; PATHOLOGICAL CONDITIONS; THERAPEUTIC INTERVENTION;

DISEASES;

BERBERINE; CURCUMIN; EPIGALLOCATECHIN GALLATE; HERBACEOUS AGENT; THIOCTIC ACID;

ALCOHOL LIVER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; HERBAL MEDICINE; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FIBROSIS; LIVER INJURY; LIVER PROTECTION; MACROPHAGE; MYELOID-DERIVED SUPPRESSOR CELL; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; REGULATORY T LYMPHOCYTE; REVIEW; SUPPRESSOR CELL; ANIMAL; BIOLOGICAL MODEL; COMPLICATION; LIVER DISEASES; PATHOLOGY; SIGNAL TRANSDUCTION;

DISEASES; PATHOLOGY;

ANIMALS; HUMANS; IMMUNOSUPPRESSION; INFLAMMATION; LIVER DISEASES; MODELS, BIOLOGICAL; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 85008873207     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/4234061     Document Type: Review

References (195)

1. J. Obert, M. Cave, and L. Marsano, "Liver diseases," World Review of Nutrition and Dietetics, vol. 111, pp. 146-150, 2015.
2. S. Li, H.-Y. Tan, N. Wang et al., "The role of oxidative stress and antioxidants in liver diseases," International Journal of Molecular Sciences, vol. 16, no. 11, pp. 26087-26124, 2015.
3. H. Cichoz-Lach and A. Michalak, "Oxidative stress as a crucial factor in liver diseases," World Journal of Gastroenterology, vol. 20, no. 25, pp. 8082-8091, 2014.
4. K. Q. de Andrade, F. A. Moura, J. M. dos Santos, O. R. P. de Araújo, J.C.D.F. Santos, and M. O. F. Goulart, "Oxidative stress and inflammation in hepatic diseases: therapeutic possibilities of N-acetylcysteine," International Journal of Molecular Sciences, vol. 16, no. 12, pp. 30269-30308, 2015.
5. C. Eckert, N. Klein, M. Kornek, and V. Lukacs-Kornek, "The complex myeloid network of the liver with diverse functional capacity at steady state and in inflammation," Frontiers in Immunology, vol. 6, article 179, 2015.
6. E. Seki and R. F. Schwabe, "Hepatic inflammation and fibrosis: functional links and key pathways," Hepatology, vol. 61, no. 3, pp. 1066-1079, 2015.
7. S. K. Biswas, "Does the interdependence between oxidative stress and inflammation explain the antioxidant paradox?" Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 5698931, 9 pages, 2016.
8. P. Lam, F. Cheung, H. Y. Tan, N. Wang, M. F. Yuen, and Y. B. Feng, "Hepatoprotective effects of Chinese medicinal herbs: a focus on anti-inflammatory and anti-oxidative activities," International Journal of Molecular Sciences, vol. 17, no. 4, p. 465, 2016.
9. B. Gao and H. Tsukamoto, "Inflammation in alcoholic and nonalcoholic fatty liver disease: friend or foe?" Gastroenterology, vol. 150, no. 8, pp. 1704-1709, 2016.
10. A. Ambade and P. Mandrekar, "Oxidative stress and inflammation: essential partners in alcoholic liver disease," International Journal of Hepatology, vol. 2012, Article ID853175, 9 pages, 2012.
11. M. Y. Bonner and J. L. Arbiser, "The antioxidant paradox: what are antioxidants and how should they be used in a therapeutic context for cancer," Future Medicinal Chemistry, vol. 6, no. 12, pp. 1413-1422, 2014.
12. B. Halliwell, "The antioxidant paradox: less paradoxical now?" British Journal of Clinical Pharmacology, vol. 75, no. 3, pp. 637-644, 2013.
13. M. W. Robinson, C. Harmon, and C. O'Farrelly, "Liver immunology and its role in inflammation and homeostasis," Cellular & Molecular Immunology, vol. 13, no. 3, pp. 267-276, 2016.
14. P. D. Ray, B.-W. Huang, and Y. Tsuji, "Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling," Cellular Signalling, vol. 24, no. 5, pp. 981-990, 2012.
15. M. Marí, A. Colell, A. Morales, C. Von Montfort, C. Garcia-Ruiz, and J. C. Fernández-Checa, "Redox control of liver function in health and disease," Antioxidants and Redox Signaling, vol. 12, no. 11, pp. 1295-1331, 2010.
16. C. Bubici, S. Papa, C. G. Pham, F. Zazzeroni, and G. Franzoso, "The NF-κB-mediated control of ROS and JNK signaling," Histology and Histopathology, vol. 21, no. 1-3, pp. 69-80, 2006.
17. H. Zhu, Z. Jia, H. Misra, and Y. R. Li, "Oxidative stress and redox signalingmechanisms of alcoholic liver disease: updated experimental and clinical evidence," Journal of Digestive Diseases, vol. 13, no. 3, pp. 133-142, 2012.
18. D. Wu and A. Cederbaum, "Oxidative stress and alcoholic liver disease," Seminars in Liver Disease, vol. 29, no. 2, pp. 141-154, 2009.
19. T. Zima and M. Kalousova, "Oxidative stress and signal transductionpathways inalcoholic liver disease," Alcoholism: Clinical & Experimental Research, vol. 29, no. 11, supplement, pp. 110S- 115S, 2005.
20. L. A. Videla, R. Rodrigo, J. Araya, and J. Poniachik, "Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease," Trends in Molecular Medicine, vol. 12, no. 12, pp. 555-558, 2006.
21. S. F. Stewart, M. Vidali, C. P. Day, E. Albano, and D. E. J. Jones, "Oxidative stress as a trigger for cellular immune responses in patients with alcoholic liver disease," Hepatology, vol. 39, no. 1, pp. 197-203, 2004.
22. M. Pawlak, P. Lefebvre, and B. Staels, "Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease," Journal of Hepatology, vol. 62, no. 3, pp. 720-733, 2015.
23. L. A. Videla, R. Rodrigo, M. Orellana et al., "Oxidative stressrelated parameters in the liver of non-alcoholic fatty liver disease patients," Clinical Science, vol. 106, no. 3, pp. 261-268, 2004.
24. V. Sánchez-Valle, N. C. Chávez-Tapia, M. Uribe, and N. Méndez-Sánchez, "Role of oxidative stress and molecular changes in liver fibrosis: a review," Current Medicinal Chemistry, vol. 19, no. 28, pp. 4850-4860, 2012.
25. M. Parola and G. Robino, "Oxidative stress-related molecules and liver fibrosis," Journal of Hepatology, vol. 35, no. 2, pp. 297-306, 2001.
26. R. Gebhardt, "Oxidative stress, plant-derived antioxidants and liver fibrosis," Planta Medica, vol. 68, no. 4, pp. 289-296, 2002.
27. Y. Baba, S. Jun-Ichiro, S. Hayashi et al., "Reduction of oxidative stress in liver cancer patients by oral green tea polyphenol tablets during hepatic arterial infusion chemotherapy," Experimental and Therapeutic Medicine, vol. 4, no. 3, pp. 452-458, 2012.
28. L. T. T. Thuy, Y. Matsumoto, T. T.V. Thuy et al., "Cytoglobin deficiency promotes liver cancer development fromhepatosteatosis through activation of the oxidative stress pathway," The American Journal of Pathology, vol. 185, no. 4, pp. 1045-1060, 2015.
29. S. Reuter, S. C. Gupta, M. M. Chaturvedi, and B. B. Aggarwal, "Oxidative stress, inflammation, and cancer: how are they linked?" Free Radical Biology and Medicine, vol. 49, no. 11, pp. 1603-1616, 2010.
30. M. Asrih and F. R. Jornayvaz, "Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance," Journal of Endocrinology, vol. 218, no. 3, pp. R25-R36, 2013.
31. H. J. Wang, B. Gao, S. Zakhari, and L. E. Nagy, "Inflammation in alcoholic liver disease," Annual Review of Nutrition, vol. 32, pp. 343-368, 2012.
32. L. Zhang, H.-Y. Song, and G. Ji, "The joint pathway of metabolism and inflammation in nonalcoholic fatty liver disease," Zhonghua Gan Zang Bing Za Zhi, vol. 19, no. 5, pp. 395-397, 2011.
33. A. C. P. Volp, F. C. S. Silva, and J. Bressan, "Hepatic inflammatory biomarkers and its link with obesity and chronic diseases," Nutricion Hospitalaria, vol. 31, no. 5, pp. 1947-1956, 2015.
34. T. Greuter and V. H. Shah, "Hepatic sinusoids in liver injury, inflammation, and fibrosis: new pathophysiological insights," Journal of Gastroenterology, vol. 51, no. 6, pp. 511-519, 2016.
35. G. Ramadori and B. Saile, "Inflammation, damage repair, immune cells, and liver fibrosis: specific or nonspecific, this is the question," Gastroenterology, vol. 127, no. 3, pp. 997-1000, 2004.
36. D. K. Stalnikowitz and A. B. Weissbrod, "Liver fibrosis and inflammation. A review," Annals of Hepatology, vol. 2, no. 4, pp. 159-163, 2003.
37. R. F. Schwabe, E. Seki, and D. A. Brenner, "Toll-Like Receptor Signaling in the Liver," Gastroenterology, vol. 130, no. 6, pp. 1886-1900, 2006.
38. L. Catrysse, M. Farhang Ghahremani, L. Vereecke et al., "A20 prevents chronic liver inflammation and cancer by protecting hepatocytes from death," Cell Death and Disease, vol. 7, no. 6, p. e2250, 2016.
39. C. Baeck and F. Tacke, "Balance of inflammatory pathways and interplay of immune cells in the liver during homeostasis and injury," EXCLI Journal, vol. 13, pp. 67-81, 2014.
40. A. J. Czaja, "Hepatic inflammation and progressive liver fibrosis in chronic liver disease," World Journal of Gastroenterology, vol. 20, no. 10, pp. 2515-2532, 2014.
41. J.-C. Nault and J. Zucman-Rossi, "Building a bridge between obesity, inflammation and liver carcinogenesis," Journal of Hepatology, vol. 53, no. 4, pp. 777-779, 2010.
42. H. Barash, E. R. Gross, Y. Edrei et al., "Accelerated carcinogenesis following liver regeneration is associated with chronic inflammation-induced double-strand DNA breaks," Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 5, pp. 2207-2212, 2010.
43. M. Mittal, M. R. Siddiqui, K. Tran, S. P. Reddy, and A. B. Malik, "Reactive oxygen species in inflammation and tissue injury," Antioxidants and Redox Signaling, vol. 20, no. 7, pp. 1126-1167, 2014.
44. L. Fialkow, Y. Wang, and G. P. Downey, "Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function," Free Radical Biology and Medicine, vol. 42, no. 2, pp. 153-164, 2007.
45. S. Salzano, P. Checconi, E.-M. Hanschmann et al., "Linkage of inflammation and oxidative stress via release of glutathionylated peroxiredoxin-2, which acts as a danger signal," Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 33, pp. 12157-12162, 2014.
46. M. P. Murphy, A. Holmgren, N.-G. Larsson et al., "Unraveling the biological roles of reactive oxygen species," Cell Metabolism, vol. 13, no. 4, pp. 361-366, 2011.
47. M. Galicia-Moreno and G. Gutiérrez-Reyes, "The role of oxidative stress in the development of alcoholic liver disease," Revista de Gastroenterologia de Mexico, vol. 79, no. 2, pp. 135-144, 2014.
48. B. Gao and R. Bataller, "Alcoholic liver disease: pathogenesis and new therapeutic targets," Gastroenterology, vol. 141, no. 5, pp. 1572-1585, 2011.
49. P. Mandal, M. T. Pritchard, and L. E. Nagy, "Anti-inflammatory pathways and alcoholic liver disease: role of an adiponectin/interleukin-10/heme oxygenase-1 pathway," World Journal of Gastroenterology, vol. 16, no. 11, pp. 1330-1336, 2010.
50. L. F. Panchenko, B. V. Davydov, N. N. Terebilina, V. I. Baronets, and A. S. Zhuravleva, "[Oxidative stress in the of alcoholic liver disease]," Biomeditsinskaia Khimiia, vol. 59, no. 4, pp. 452-458, 2013.
51. S. Bala, T. Csak, B. Saha et al., "The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis," Journal of Hepatology, vol. 64, no. 6, pp. 1378-1387, 2016.
52. H. Tilg and A. R. Moschen, "Insulin resistance, inflammation, and non-alcoholic fatty liver disease," Trends in Endocrinology and Metabolism, vol. 19, no. 10, pp. 371-379, 2008.
53. V. Thakur, M. T. Pritchard, M. R. McMullen, Q. Wang, and L. E. Nagy, "Chronic ethanol feeding increases activation of NADPH oxidase by lipopolysaccharide in rat Kupffer cells: role of increased reactive oxygen in LPS-stimulated ERK1/2 activation and TNF-α production," Journal of Leukocyte Biology, vol. 79, no. 6, pp. 1348-1356, 2006.
54. P. Mandrekar and G. Szabo, "Signalling pathways in alcoholinduced liver inflammation," Journal of Hepatology, vol. 50, no. 6, pp. 1258-1266, 2009.
55. C. Wang, X. Li, H. Wang, Q. Xie, and Y. Xu, "Notch1-nuclear factor κB involves in oxidative stress-induced alcoholic steatohepatitis," Alcohol and Alcoholism, vol. 49, no. 1, Article ID agt167, pp. 10-16, 2014.
56. D. Dong, W. Zhong, Q. Sun, W. Zhang, X. Sun, and Z. Zhou, "Oxidative products from alcohol metabolism differentially modulate pro-inflammatory cytokine expression in Kupffer cells and hepatocytes," Cytokine, vol. 85, pp. 109-119, 2016.
57. H. Tilg and A. R. Moschen, "Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis," Hepatology, vol. 52, no. 5, pp. 1836-1846, 2010.
58. H. Tilg and A. Moschen, "Update on nonalcoholic fatty liver disease: genes involved in nonalcoholic fatty liver disease and associated inflammation," Current Opinion in Clinical Nutrition and Metabolic Care, vol. 13, no. 4, pp. 391-396, 2010.
59. E. A. Rakha, L. Adamson, E. Bell et al., "Portal inflammation is associated with advanced histological changes in alcoholic and non-alcoholic fatty liver disease," Journal of Clinical Pathology, vol. 63, no. 9, pp. 790-795, 2010.
60. M. Foroughi, Z. Maghsoudi, S. Khayyatzadeh, R. Ghiasvand, G. Askari, and B. Iraj, "Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver," Advanced Biomedical Research, vol. 5, article 28, 2016.
61. A. Takaki, D. Kawai, and K. Yamamoto, "Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH)," International Journal of Molecular Sciences, vol. 14, no. 10, pp. 20704-20728, 2013.
62. C. S. Voican and G. Perlemuter, "Insulin resistance and oxidative stress: two therapeutic targets in non-alcoholic steatohepatitis," Journal of Hepatology, vol. 54, no. 2, pp. 388-391, 2011.
63. D. Thong-Ngam, S. Samuhasaneeto, O. Kulaputana, and N. Klaikeaw, "N-acetylcysteine attenuates oxidative stress and liver pathology in rats with non-alcoholic steatohepatitis," World Journal of Gastroenterology, vol. 13, no. 38, pp. 5127-5132, 2007.
64. G. H. Koek, P. R. Liedorp, and A. Bast, "The role of oxidative stress in non-alcoholic steatohepatitis," Clinica Chimica Acta, vol. 412, no. 15-16, pp. 1297-1305, 2011.
65. N. Torer, S. Ozenirler, A. Yucel, N. Bukan, and O. Erdem, "Importance of cytokines, oxidative stress and expression of BCL-2 in the pathogenesis of non-alcoholic steatohepatitis," Scandinavian Journal of Gastroenterology, vol. 42, no. 9, pp. 1095-1101, 2007.
66. H. Mitsuyoshi, Y. Itoh, and T. Okanoue, "Role of oxidative stress in non-alcoholic steatohepatitis," Nippon Rinsho, vol. 64, no. 6, pp. 1077-1082, 2006.
67. E. Kathirvel, P. Chen, K. Morgan, S. W. French, and T. R. Morgan, "Oxidative stress and regulation of anti-oxidant enzymes in cytochrome P4502E1 transgenic mousemodel of non-alcoholic fatty liver," Journal of Gastroenterology and Hepatology, vol. 25, no. 6, pp. 1136-1143, 2010.
68. T. Okanoue and H. Mitsuyoshi, "[Non-alcoholic steatohepatitis. 3. Oxidative stress and NASH],"Nihon Naika Gakkai Zasshi, vol. 95, no. 1, pp. 51-56, 2006.
69. D. T. Reid, J. L. Reyes, B. A. McDonald et al., "Kupffer cells undergo fundamental changes during the development of experimental NASH and are critical in initiating liver damage and inflammation," PLoS ONE, vol. 11, no. 7, Article ID e0159524, 2016.
70. Y. Cepero-Donates, G. Lacraz, F. Ghobadi et al., "Interleukin- 15-mediated inflammation promotes non-alcoholic fatty liver disease," Cytokine, vol. 82, pp. 102-111, 2016.
71. M. Xiang, P. Wang, A. Wang et al., "Targeting hepatic TRAF1- ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis," Journal of Hepatology, vol. 64, no. 6, pp. 1365-1377, 2016.
72. L. Bavia, Ý. A. de Castro, B. Cogliati, J. B. Dettoni, V. A. F. Alves, and L. Isaac, "Complement C5 controls liver lipid profile, promotes liver homeostasis and inflammation in C57BL/6 genetic background," Immunobiology, vol. 221, no. 7, pp. 822-832, 2016.
73. N. Nishida, N. Yada, S. Hagiwara, T. Sakurai, M. Kitano, and M. Kudo, "Unique features associated with hepatic oxidative DNA damage and DNA methylation in non-alcoholic fatty liver disease," Journal of Gastroenterology and Hepatology, vol. 31, no. 9, pp. 1646-1653, 2016.
74. G. Baskol, M. Baskol, and D. Kocer, "Oxidative stress and antioxidant defenses in serum of patients with non-alcoholic steatohepatitis," Clinical Biochemistry, vol. 40, no. 11, pp. 776-780, 2007.
75. S. Seki, T. Kitada, T. Yamada, H. Sakaguchi, K. Nakatani, and K. Wakasa, "In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases," Journal of Hepatology, vol. 37, no. 1, pp. 56-62, 2002.
76. E. Albano, E. Mottaran, M. Vidali et al., "Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis," Gut, vol. 54, no. 7, pp. 987-993, 2005.
77. V. Nobili, M. Parola, A. Alisi et al., "Oxidative stress parameters in paediatric non-alcoholic fatty liver disease," International Journal of Molecular Medicine, vol. 26, no. 4, pp. 471-476, 2010.
78. S. Satapati, B. Kucejova, J. A. G. Duarte et al., "Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver," Journal of Clinical Investigation, vol. 125, no. 12, pp. 4447-4462, 2015.
79. S. Sakaguchi, S. Takahashi, T. Sasaki, T. Kumagai, and K. Nagata, "Progression of alcoholic and non-alcoholic steatohepatitis: common metabolic aspects of innate immune system and oxidative stress," Drug Metabolism and Pharmacokinetics, vol. 26, no. 1, pp. 30-46, 2011.
80. R. Kumar, S. Prakash, S. Chhabra et al., "Association of proinflammatory cytokines, adipokines & oxidative stress with insulin resistance & non-alcoholic fatty liver disease," Indian Journal of Medical Research, vol. 136, no. 2, pp. 229-236, 2012.
81. S. L. Devi and C. V. Anuradha, "Oxidative and nitrosative stress in experimental rat liver fibrosis: protective effect of taurine," Environmental Toxicology and Pharmacology, vol. 29, no. 2, pp. 104-110, 2010.
82. G. Poli, "Pathogenesis of liver fibrosis: role of oxidative stress," Molecular Aspects of Medicine, vol. 21, no. 3, pp. 49-98, 2000.
83. G. H. Heeba and M. E. Mahmoud, "Therapeutic potential of morin against liver fibrosis in rats: modulation of oxidative stress, cytokine production and nuclear factor kappa B," Environmental Toxicology and Pharmacology, vol. 37, no. 2, pp. 662-671, 2014.
84. H. Yamamoto, K. Kanno, T. Ikuta et al., "Enhancing hepatic fibrosis in spontaneously hypertensive rats fed a cholinedeficient diet: a follow-up report on long-term effects of oxidative stress in non-alcoholic fatty liver disease," Journal of Hepato-Biliary-Pancreatic Sciences, vol. 23, no. 5, pp. 260-269, 2016.
85. H.-L. Ha, H.-J. Shin, M. A. Feitelson, and D.-Y. Yu, "Oxidative stress and antioxidants in hepatic pathogenesis," World Journal of Gastroenterology, vol. 16, no. 48, pp. 6035-6043, 2010.
86. S.-S. Zhan, J. X. Jiang, J. Wu et al., "Phagocytosis of apoptotic bodies by hepatic stellate cells induces NADPH oxidase and is associated with liver fibrosis in vivo," Hepatology, vol. 43, no. 3, pp. 435-443, 2006.
87. Z. D. Goodman, "Grading and staging systems for inflammation and fibrosis in chronic liver diseases," Journal of Hepatology, vol. 47, no. 4, pp. 598-607, 2007.
88. M. Ganz, T. N. Bukong, T. Csak et al., "Progression of nonalcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice," Journal of Translational Medicine, vol. 13, no. 1, article no. 193, 2015.
89. J. P. Iredale, "Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ," Journal of Clinical Investigation, vol. 117, no. 3, pp. 539-548, 2007.
90. R. Lavieri, P. Piccioli, S. Carta, L. Delfino, P. Castellani, and A. Rubartelli, "TLR costimulation causes oxidative stress with unbalance of proinflammatory and anti-inflammatory cytokine production," The Journal of Immunology, vol. 192, no. 11, pp. 5373-5381, 2014.
91. P. Handa and K. V. Kowdley, "Chemokines: potent mediators of hepatic inflammation and fibrosis in chronic liver diseases," Annals of Hepatology, vol. 13, no. 1, pp. 152-154, 2014.
92. F. Marra, "Chemokines in liver inflammation and fibrosis," Frontiers in Bioscience, vol. 7, pp. d1899-d1914, 2002.
93. H.W. Zimmermann and F. Tacke, "Modification of chemokine pathways and immune cell infiltration as a novel therapeutic approach in liver inflammation and fibrosis," Inflammation and Allergy-Drug Targets, vol. 10, no. 6, pp. 509-536, 2011.
94. S. Sutti, A. Jindal, S. Bruzzi, I. Locatelli, C. Bozzola, and E. Albano, "Is there a role for adaptive immunity in nonalcoholic steatohepatitis?" World Journal of Hepatology, vol. 7, no. 13, pp. 1725-1729, 2015.
95. X. Wan, C. Xu, C. Yu, and Y. Li, "Role of NLRP3 inflammasome in the progression of NAFLD to NASH," Canadian Journal of Gastroenterology and Hepatology, vol. 2016, Article ID 6489012, 7 pages, 2016.
96. M. Rau, A.-K. Schilling, J. Meertens et al., "Progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis is marked by a higher frequency of Th17 cells in the liver and an increased Th17/resting regulatory T cell ratio in peripheral blood and in the liver," Journal of Immunology, vol. 196, no. 1, pp. 97-105, 2016.
97. S. Sutti, A. Jindal, I. Locatelli et al., "Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH," Hepatology, vol. 59, no. 3, pp. 886-897, 2014.
98. V. L. Gadd, R. Skoien, E. E. Powell et al., "The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease," Hepatology, vol. 59, no. 4, pp. 1393-1405, 2014.
99. J. Li, R. Fan, S. Zhao et al., "Reactive oxygen species released from hypoxic hepatocytes regulates MMP-2 expression in hepatic stellate cells," International Journal of Molecular Sciences, vol. 12, no. 4, pp. 2434-2447, 2011.
100. B. Hu, M. Sun, J. Liu, G. Hong, and Q. Lin, "The preventative effect of Akt knockout on liver cancer through modulating NF- κB-regulated inflammation and Bad-related apoptosis signaling pathway," International Journal of Oncology, vol. 48, no. 4, pp. 1467-1476, 2016.
101. N. Shivappa, J. R. Hébert, J. Polesel et al., "Inflammatory potential of diet and risk for hepatocellular cancer in a casecontrol study from Italy," British Journal of Nutrition, vol. 115, no. 2, pp. 324-331, 2016.
102. B. Alzahrani, T. J. Iseli, and L.W. Hebbard, "Non-viral causes of liver cancer: does obesity led inflammation play a role?" Cancer Letters, vol. 345, no. 2, pp. 223-229, 2014.
103. B. Sun and M. Karin, "Obesity, inflammation, and liver cancer," Journal of Hepatology, vol. 56, no. 3, pp. 704-713, 2012.
104. T. Zahavi, T. Lanton, M. S. Divon et al., "Sorafenib treatment during partial hepatectomy reduces tumorgenesis in an inflammation-associated liver cancer model," Oncotarget, vol. 7, no. 4, pp. 4860-4870, 2016.
105. S. C. Chang and J. L. Ding, "SAG-UPS regulates malignant transformation-from chronic inflammation to pro-tumorigenesis to liver cancer," Cell Death & Disease, vol. 6, no. 10, Article ID e1941, 2015.
106. L. Liu, Z. Yang, Y. Xu et al., "Inhibition of oxidative stresselicited AKT activation facilitates PPARγ agonist-mediated inhibition of stem cell character and tumor growth of liver cancer cells," PLoS ONE, vol. 8, no. 8, Article ID e73038, 2013.
107. V. Bieghs and C. Trautwein, "The innate immune response during liver inflammation and metabolic disease," Trends in Immunology, vol. 34, no. 9, pp. 447-452, 2013.
108. R. Liberal, C. R. Grant, M. S. Longhi, G. Mieli-Vergani, and D. Vergani, "Regulatory T cells: mechanisms of suppression and impairment in autoimmune liver disease," IUBMB Life, vol. 67, no. 2, pp. 88-97, 2015.
109. L. Lu, M. Feng, J. Gu et al., "Restoration of intrahepatic regulatory T cells through MMP-9/13-dependent activation of TGF-β is critical for immune homeostasis following acute liver injury," Journal of Molecular Cell Biology, vol. 5, no. 6, pp. 369-379, 2013.
110. Y. S. Roh, S. Park, C.W. Lim, and B. Kim, "Depletion of Foxp3+ regulatory T cells promotes profibrogenic milieu of cholestasisinduced liver injury," Digestive Diseases and Sciences, vol. 60, no. 7, pp. 2009-2018, 2015.
111. Y. H. Oo, C. J. Weston, P. F. Lalor et al., "Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver," The Journal of Immunology, vol. 184, no. 6, pp. 2886-2898, 2010.
112. M. Lian, W. Luo, Y. Sui, Z. Li, and J. Hua, "Dietary n-3 PUFA protects mice from Con a induced liver injury by modulating regulatory T cells and PPAR-γ expression," PLoS ONE, vol. 10, no. 7, Article ID e0132741, 2015.
113. M. Feng, Q. Wang, F. Zhang, and L. Lu, "Ex vivo induced regulatory T cells regulate inflammatory response of Kupffer cells by TGF-beta and attenuate liver ischemia reperfusion injury," International Immunopharmacology, vol. 12, no. 1, pp. 189-196, 2012.
114. X. Wang, R. Sun, Y. Chen, Z.-X. Lian, H. Wei, and Z. Tian, "Regulatory T cells ameliorate acetaminophen-induced immunemediated liver injury," International Immunopharmacology, vol. 25, no. 2, pp. 293-301, 2015.
115. D.-H. Xu, F. Liu, X. Li et al., "Regulatory role of nucleophosmin during the differentiation of human liver cancer cells," International Journal of Oncology, vol. 45, no. 1, pp. 264-272, 2014.
116. F. Li, Z. Guo, G. Lizée, H. Yu, H. Wang, and T. Si, "Clinical prognostic value of CD4+CD25+FOXP3+regulatory T cells in peripheral blood of Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma patients," Clinical Chemistry and Laboratory Medicine, vol. 52, no. 9, pp. 1357-1365, 2014.
117. M. Zabala, J. J. Lasarte, C. Perret et al., "Induction of immunosuppressive molecules and regulatory T cells counteracts the antitumor effect of interleukin-12-based gene therapy in a transgenic mouse model of liver cancer," Journal of Hepatology, vol. 47, no. 6, pp. 807-815, 2007.
118. S. Tavakolpour, "Inhibition of regulatory cells as a possible cure of chronically hepatitis B virus infected patients," Immunology Letters, vol. 171, pp. 70-71, 2016.
119. M. R. Fernando, J. L. Reyes, J. Iannuzzi, G. Leung, and D. M. McKay, "The pro-inflammatory cytokine, interleukin-6, enhances the polarization of alternatively activatedmacrophages," PLoS ONE, vol. 9, no. 4, Article ID e94188, 2014.
120. J. Lee, B. French, T. Morgan, and S. W. French, "The liver is populated by a broad spectrum of markers for macrophages. In alcoholic hepatitis the macrophages are M1 and M2," Experimental and Molecular Pathology, vol. 96, no. 1, pp. 118-125, 2014.
121. J. Wan, M. Benkdane, F. Teixeira-Clerc et al., "M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease," Hepatology, vol. 59, no. 1, pp. 130-142, 2014.
122. J. Wan, M. Benkdane, E. Alons, S. Lotersztajn, and C. Pavoine, "M2 Kupffer cells promote hepatocyte senescence: an IL-6- dependent protective mechanism against alcoholic liver disease," The American Journal of Pathology, vol. 184, no. 6, pp. 1763-1772, 2014.
123. B. Saha, S. Bala, N. Hosseini, K. Kodys, and G. Szabo, "Krüppellike factor 4 is a transcriptional regulator of M1/M2macrophage polarization in alcoholic liver disease," Journal of Leukocyte Biology, vol. 97, no. 5, pp. 963-973, 2015.
124. K. K. Wijesundera, T. Izawa, H. Murakami et al., "M1- and M2- macrophage polarization in thioacetamide (TAA)-induced rat liver lesions; a possible analysis for hepato-pathology," Histology and Histopathology, vol. 29, no. 4, pp. 497-511, 2014.
125. A. Sica, P. Invernizzi, and A. Mantovani, "Macrophage plasticity and polarization in liver homeostasis and pathology," Hepatology, vol. 59, no. 5, pp. 2034-2042, 2014.
126. L. Beattie, A. Sawtell, J. Mann et al., "Liver Macrophage Function is Guided by Micro-environment rather than Origin," Journal of Hepatology, In press.
127. D. I. Gabrilovich and S. Nagaraj, "Myeloid-derived suppressor cells as regulators of the immune system," Nature Reviews Immunology, vol. 9, no. 3, pp. 162-174, 2009.
128. S. K. Bunt, V. K. Clements, E. M. Hanson, P. Sinha, and S. Ostrand-Rosenberg, "Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4," Journal of Leukocyte Biology, vol. 85, no. 6, pp. 996-1004, 2009.
129. W. Diao, F. Jin, B. Wang et al., "The protective role of myeloidderived suppressor cells in concanavalin A-induced hepatic injury," Protein & Cell, vol. 5, no. 9, pp. 714-724, 2014.
130. Y. Kwak, H. E. Kim, and S. G. Park, "Insights into myeloidderived suppressor cells in inflammatory diseases," Archivum Immunologiae et Therapiae Experimentalis, vol. 63, no. 4, pp. 269-285, 2015.
131. A. R. Arocena, L. I. Onofrio, A. V. Pellegrini et al., "Myeloidderived suppressor cells are key players in the resolution of inflammation during a model of acute infection," European Journal of Immunology, vol. 44, no. 1, pp. 184-194, 2014.
132. H. Zhang, Y. Liu, Z. Bian et al., "The critical role of myeloidderived suppressor cells and FXR activation in immunemediated liver injury," Journal of Autoimmunity, vol. 53, pp. 55-66, 2014.
133. J. G. Cripps, J. Wang, A. Maria, I. Blumenthal, and J.D. Gorham, "Type 1 T helper cells induce the accumulation of myeloidderived suppressor cells in the inflamed Tgfb1 knockout mouse liver," Hepatology, vol. 52, no. 4, pp. 1350-1359, 2010.
134. Y. Zhang, Y. Bi, H. Yang et al., "mTOR limits the recruitment of CD11b+Gr1+Ly6Chighmyeloid-derived suppressor cells in protecting against murine immunological hepatic injury," Journal of Leukocyte Biology, vol. 95, no. 6, pp. 961-970, 2014.
135. G. Liu, Y. Bi, R. Wang et al., "Targeting S1P1 receptor protects againstmurine immunological hepatic injury throughmyeloidderived suppressor cells," The Journal of Immunology, vol. 192, no. 7, pp. 3068-3079, 2014.
136. B. Höchst, F. A. Schildberg, P. Sauerborn et al., "Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion," Journal of Hepatology, vol. 59, no. 3, pp. 528-535, 2013.
137. X. Ma, J. Hua, A. R. Mohamood, A. R. A. Hamad, R. Ravi, and Z. Li, "Ahigh-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury," Hepatology, vol. 46, no. 5, pp. 1519-1529, 2007.
138. Y. J. Resheq, K.-K. Li, S. T. Ward et al., "Contact-dependent depletion of hydrogen peroxide by catalase is a novel mechanism ofmyeloid-derived suppressor cell induction operating in human hepatic stellate cells," The Journal of Immunology, vol. 194, no. 6, pp. 2578-2586, 2015.
139. 4-mediated oxidative stress and hepatic fibrosis by down-regulating TNF-α/NF-κB, and pro-fibrotic factor TGF- β1 mediating inflammatory signaling," Toxicology and Industrial Health, vol. 32, no. 5, pp. 953-960, 2016.
140. R. Teraoka, T. Shimada, and M. Aburada, "The molecular mechanisms of the hepatoprotective effect of gomisin a against oxidative stress and inflammatory response in rats with carbon tetrachloride-induced acute liver injury," Biological and Pharmaceutical Bulletin, vol. 35, no. 2, pp. 171-177, 2012.
141. M. D. Shah, C. Gnanaraj, M. S. Khan, and M. Iqbal, "Dillenia Suffruticosa L. impedes carbon tetrachloride-induced hepatic damage by modulating oxidative stress and inflammatory markers in rats," Journal of Environmental Pathology, Toxicology and Oncology, vol. 34, no. 2, pp. 133-152, 2015.
142. I.-C. Lee, S.-H. Kim, H.-S. Baek et al., "The involvement of Nrf2 in the protective effects of diallyl disulfide on carbon tetrachloride-induced hepatic oxidative damage and inflammatory response in rats," Food and Chemical Toxicology, vol. 63, pp. 174-185, 2014.
143. H. Ebaid, S. A. E. Bashandy, I. M. Alhazza, A. Rady, and S. El-Shehry, "Folic acid and melatonin ameliorate carbon tetrachloride-induced hepatic injury, oxidative stress and inflammation in rats," Nutrition & Metabolism, vol. 10, no. 1, article 20, 2013.
144. 4-induced oxidative stress and inflammation by the MAPK/NF-κB pathway," Environmental Toxicology and Pharmacology, vol. 37, no. 3, pp. 975-983, 2014.
145. Y. Cui, Q. Ye, H. Wang et al., "Aloin protects against chronic alcoholic liver injury via attenuating lipid accumulation, oxidative stress and inflammation in mice," Archives of Pharmacal Research, vol. 37, no. 12, pp. 1624-1633, 2014.
146. K.-H. Lu, H.-C. Tseng, C.-T. Liu, C.-J. Huang, J.-H. Chyuan, and L.-Y. Sheen, "Wild bitter gourd protects against alcoholic fatty liver in mice by attenuating oxidative stress and inflammatory responses," Food and Function, vol. 5, no. 5, pp. 1027-1037, 2014.
147. S.-Y. Du, Y.-L. Zhang, R.-X. Bai, Z.-L. Ai, B.-S. Xie, and H.- Y. Yang, "Lutein prevents alcohol-induced liver disease in rats bymodulating oxidative stress and inflammation," International Journal of Clinical and Experimental Medicine, vol. 8, no. 6, pp. 8785-8793, 2015.
148. G.H. Heeba and M. A. Morsy, "Fucoidanameliorates steatohepatitis and insulin resistance by suppressing oxidative stress and inflammatory cytokines in experimental non-alcoholic fatty liver disease," Environmental Toxicology and Pharmacology, vol. 40, no. 3, pp. 907-914, 2015.
149. J. Xiao, C. T. Ho, E. C. Liong et al., "Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in nonalcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways," European Journal of Nutrition, vol. 53, no. 1, pp. 187-199, 2014.
150. J. Wang, C. Zhang, Z. Zhang et al., "BL153 partially prevents high-fat diet induced liver damage probably via inhibition of lipid accumulation, inflammation, and oxidative stress," Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 674690, 10 pages, 2014.
151. H. Eo, Y.-J. Jeon, M. Lee, and Y. Lim, "Brown alga Ecklonia cava polyphenol extract ameliorates hepatic lipogenesis, oxidative stress, and inflammation by activation of AMPK and SIRT1 in high-fat diet-induced obese mice," Journal of Agricultural and Food Chemistry, vol. 63, no. 1, pp. 349-359, 2015.
152. H. Xiao, G. Xie, J. Wang et al., "Chicoric acid prevents obesity by attenuating hepatic steatosis, inflammation and oxidative stress in high-fat diet-fed mice," Food Research International, vol. 54, no. 1, pp. 345-353, 2013.
153. Y. Li, J. Hai, L. Li et al., "Administration of ghrelin improves inflammation, oxidative stress, and apoptosis during and after non-alcoholic fatty liver disease development," Endocrine, vol. 43, no. 2, pp. 376-386, 2013.
154. S. O. Ali, H. A. Darwish, and N. A. Ismail, "Curcumin, silybin phytosome and α-R-lipoic acid mitigate chronic hepatitis in rat by inhibiting oxidative stress and inflammatory cytokines production," Basic and Clinical Pharmacology and Toxicology, vol. 118, no. 5, pp. 369-380, 2015.
155. S. Nafees, S. T. Ahmad, W. Arjumand, S. Rashid, N. Ali, and S. Sultana, "Carvacrol ameliorates thioacetamide-induced hepatotoxicity by abrogation of oxidative stress, inflammation, and apoptosis in liver of Wistar rats," Human and Experimental Toxicology, vol. 32, no. 12, pp. 1292-1304, 2013.
156. O. R.A. Ajuwon, O. O. M. Oguntibeju, and J. L. U. Marnewick, "Amelioration of lipopolysaccharide-induced liver injury by aqueous rooibos (Aspalathus linearis) extract via inhibition of pro-inflammatory cytokines and oxidative stress," BMC Complementary and Alternative Medicine, vol. 14, p. 392, 2014.
157. X. Xia, C. Su, J. Fu et al., "Role of α-lipoic acid in LPS/d-GalN induced fulminant hepatic failure in mice: studies on oxidative stress, inflammation and apoptosis," International Immunopharmacology, vol. 22, no. 2, pp. 293-302, 2014.
158. Y. Tao, Z. Wen, Y. Song, and H. Wang, "Paeoniflorin attenuates hepatic ischemia/reperfusion injury via anti-oxidative, antiinflammatory and anti-apoptotic pathways," Experimental and Therapeutic Medicine, vol. 11, no. 1, pp. 263-268, 2016.
159. X.-Q. Zhao, B. Liang, Y. Liu, and X.-Q. Huang, "Agaricoglycerides protect against hepatic ischemia/reperfusion injury by attenuating inflammatory response, oxidative stress, and expression of NF-κB," Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 142736, 6 pages, 2015.
160. P. Mukhopadhyay, M. Rajesh, B. Horváth et al., "Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death," Free Radical Biology and Medicine, vol. 50, no. 10, pp. 1368-1381, 2011.
161. X. Tao, X. Wan, Y. Xu et al., "Dioscin attenuates hepatic ischemia-reperfusion injury in rats through inhibition of oxidative-nitrative stress, inflammation and apoptosis," Transplantation, vol. 98, no. 6, pp. 604-611, 2014.
162. 2 receptors," British Journal of Pharmacology, vol. 165, no. 8, pp. 2450-2461, 2012.
163. B. Relja, E. Töttel, L. Breig et al., "Plant polyphenols attenuate hepatic injury after hemorrhage/resuscitation by inhibition of apoptosis, oxidative stress, and inflammation via NF-kappaB in rats," European Journal of Nutrition, vol. 51, no. 3, pp. 311-321, 2012.
164. C.H. Park, F. H. Xu, S.-S. Roh et al., "Astaxanthin and corni fructus protect against diabetes-induced oxidative stress, inflammation, and advanced glycation end product in livers of streptozotocin-induced diabetic rats," Journal of Medicinal Food, vol. 18, no. 3, pp. 337-344, 2015.
165. C.-C. Chang, C.-Y. Chang, J.-P. Huang, and L.-M. Hung, "Effect of resveratrol on oxidative and inflammatory stress in liver and spleen of streptozotocin-induced type 1 diabetic rats," Chinese Journal of Physiology, vol. 55, no. 3, pp. 1-10, 2012.
166. 1-induced liver oxidative damage and inflammatory responses in broilers," Toxins, vol. 7, no. 12, pp. 5435-5447, 2015.
167. S. H. Ganji, M. L. Kashyap, and V. S. Kamanna, "Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: impact on non-alcoholic fatty liver disease," Metabolism: Clinical and Experimental, vol. 64, no. 9, pp. 982-990, 2015.
168. J. Wang, M. Miao, Y. Zhang et al., "Quercetin ameliorates liver injury induced with Tripterygium glycosides by reducing oxidative stress and inflammation," Canadian Journal of Physiology and Pharmacology, vol. 93, no. 6, pp. 427-433, 2015.
169. +-depletion," Journal of Hazardous Materials, vol. 283, pp. 98-109, 2014.
170. S. K. Hasan and S. Sultana, "Geraniol attenuates 2-acetylaminofluorene induced oxidative stress, inflammation and apoptosis in the liver of wistar rats," Toxicology Mechanisms and Methods, vol. 25, no. 7, pp. 559-573, 2015.
171. S. R. Galaly, O. M. Ahmed, and A. M. Mahmoud, "Thymoquinone and curcumin prevent gentamicin-induced liver injury by attenuating oxidative stress, inflammation and apoptosis," Journal of Physiology and Pharmacology, vol. 65, no. 6, pp. 823-832, 2014.
172. M. U. Rehman, N. Ali, S. Rashid et al., "Alleviation of hepatic injury by chrysin in cisplatin administered rats: probable role of oxidative and inflammatory markers," Pharmacological Reports, vol. 66, no. 6, pp. 1050-1059, 2014.
173. E. Song, J. Fu, X. Xia, C. Su, and Y. Song, "Bazhen decoction protects against acetaminophen induced acute liver injury by inhibiting oxidative stress, inflammation and apoptosis in mice," PLoS ONE, vol. 9, no. 9, Article ID e107405, 2014.
174. Y. Wang, Y. Li, J. Xie et al., "Protective effects of probiotic Lactobacillus casei Zhang against endotoxin- and d-galactosamine-induced liver injury in rats via anti-oxidative and antiinflammatory capacities," International Immunopharmacology, vol. 15, no. 1, pp. 30-37, 2013.
175. J. E. Kim, R. M. Clark, Y. Park, J. Lee, and M. L. Fernandez, "Lutein decreases oxidative stress and inflammation in liver and eyes of Guinea Pigs fed a hypercholesterolemic diet," Nutrition Research and Practice, vol. 6, no. 2, pp. 113-119, 2012.
176. A. S. Sivakumar and C. V. Anuradha, "Effect of galangin supplementation on oxidative damage and inflammatory changes in fructose-fed rat liver," Chemico-Biological Interactions, vol. 193, no. 2, pp. 141-148, 2011.
177. J.-Q. Ma, C.-M. Liu, Z.-H. Qin, J.-H. Jiang, and Y.-Z. Sun, "Ganoderma applanatum terpenes protect mouse liver against benzo(α)pyren-induced oxidative stress and inflammation," Environmental Toxicology and Pharmacology, vol. 31, no. 3, pp. 460-468, 2011.
178. F. Duval, J. E. Moreno-Cuevas, M. T. González-Garza, C. Maldonado-Bernal, and D. E. Cruz-Vega, "Liver fibrosis and mechanisms of the protective action of medicinal plants targeting inflammation and the immune response," International Journal of Inflammation, vol. 2015, Article ID 943497, 14 pages, 2015.
179. N. Wang, Y. Feng, M. Zhu et al., "Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: the cellular mechanism," Journal of Cellular Biochemistry, vol. 111, no. 6, pp. 1426-1436, 2010.
180. H. Y. Tan, N. Wang, S.-W. Tsao, Z. Zhang, and Y. Feng, "Suppression of vascular endothelial growth factor via inactivation of eukaryotic elongation factor 2 by alkaloids in Coptidis rhizome in hepatocellular carcinoma," Integrative Cancer Therapies, vol. 13, no. 5, pp. 425-434, 2014.
181. N. Wang, M. Zhu, X. Wang, H.-Y. Tan, S.-W. Tsao, and Y. Feng, "Berberine-induced tumor suppressor p53 up-regulation gets involved in the regulatory network of MIR-23a in hepatocellular carcinoma," Biochimica et Biophysica Acta-Gene Regulatory Mechanisms, vol. 1839, no. 9, pp. 849-857, 2014.
182. Z. Zhang, B. Li, X. Meng et al., "Berberine prevents progression fromhepatic steatosis to steatohepatitis and fibrosis by reducing endoplasmic reticulum stress," Scientific Reports, vol. 6, Article ID 20848, 2016.
183. D. A. Ghareeb, S. Khalil, H. S. Hafez et al., "Berberine reduces neurotoxicity related to nonalcoholic steatohepatitis in rats," Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 361847, 13 pages, 2015.
184. Y.-Q. Shan, G. Ren, Y.-X. Wang et al., "Berberine analogue IMBY53 improves glucose-lowering efficacy by averting cellular efflux especially P-glycoprotein efflux," Metabolism: Clinical and Experimental, vol. 62, no. 3, pp. 446-456, 2013.
185. J. Li, Y. Pan, M. Kan et al., "Hepatoprotective effects of berberine on liver fibrosis via activation of AMP-activated protein kinase," Life Sciences, vol. 98, no. 1, pp. 24-30, 2014.
186. R. Domitrović, H. Jakovac, and G. Blagojević, "Hepatoprotective activity of berberine is mediated by inhibition of TNF- α, COX-2, and iNOS expression in CCl4-intoxicated mice," Toxicology, vol. 280, no. 1-2, pp. 33-43, 2011.
187. A. M. Mahmoud and H. S. Al Dera, "18β-Glycyrrhetinic acid exerts protective effects against cyclophosphamide-induced hepatotoxicity: potential role of PPARγ and Nrf2 upregulation," Genes & Nutrition, vol. 10, no. 6, article 41, 2015.
188. M. O. Germoush and A. M. Mahmoud, "Berberine mitigates cyclophosphamide-induced hepatotoxicity by modulating antioxidant status and inflammatory cytokines," Journal of Cancer Research and Clinical Oncology, vol. 140, no. 7, pp. 1103-1109, 2014.
189. 4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation," Molecular Pharmacology, vol. 73, no. 2, pp. 399-409, 2008.
190. D. Xu, L. Hu, C. Su et al., "Tetrachloro-p-benzoquinone induces hepatic oxidative damage and inflammatory response, but not apoptosis in mouse: the prevention of curcumin," Toxicology and Applied Pharmacology, vol. 280, no. 2, pp. 305-313, 2014.
191. K. Shen, X. Feng, R. Su, H. Xie, L. Zhou, and S. Zheng, "Epigallocatechin 3-gallate ameliorates bile duct ligation induced liver injury in mice by modulation of mitochondrial oxidative stress and inflammation," PLoS ONE, vol. 10, no. 5, Article ID e0126278, 2015.
192. 4)-induced liver injury in mice," Toxicology, vol. 273, no. 1-3, pp. 45-52, 2010.
193. Y. Niu, L. Na, R. Feng et al., "Thephytochemical, EGCG, extends lifespan by reducing liver and kidney function damage and improving age-associated inflammation and oxidative stress in healthy rats," Aging Cell, vol. 12, no. 6, pp. 1041-1049, 2013.
194. A. Goraca, H. Huk-Kolega, A. Kowalczyk, and B. Skibska, "Antioxidative and anti-inflammatory effects of lipoic acid in rat liver," Postȩpy Higieny i Medycyny Doświadczalnej, vol. 69, pp. 270-276, 2015.
195. M. C. Castro, M. L. Massa, L. G. Arbeláez, G. Schinella, J. J. Gagliardino, and F. Francini, "Fructose-induced inflammation, insulin resistance and oxidative stress: a liver pathological triad effectively disrupted by lipoic acid," Life Sciences, vol. 137, pp. 1-6, 2015.